← Back to Search

Supraclavicular BPNB for Phrenic Nerve Paralysis

N/A
Waitlist Available
Led By Kamen Vlassakov, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes post block
Awards & highlights
No Placebo-Only Group

Summary

The aim of this study is to evaluate differences between ultrasound guided supraclavicular versus retroclavicular brachial plexus blocks: two similar brachial plexus nerve block techniques that differ in their needle trajectory and injection site.

Eligible Conditions
  • Phrenic Nerve Paralysis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes post block, then postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes post block, then postoperatively for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of IIpsilateral Diaphragmatic Paresis
Secondary study objectives
Anesthetic and analgesic efficacy
Complication rates
Nerve block distribution
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Supraclavicular BPNBActive Control1 Intervention
Patients in this group will be randomized to receive an Ultrasound Guided Supraclavicular Brachial Plexus Nerve Block and outcomes will be measured over the perioperative and 1day time period.
Group II: Retroclavicular BNPBActive Control1 Intervention
Patients in this group will be randomized to receive an Ultrasound Guided Retroclavicular Brachial Plexus Nerve Block and outcomes will be measured over the perioperative and 1day time period.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,666 Previous Clinical Trials
11,840,191 Total Patients Enrolled
Kamen Vlassakov, MDPrincipal Investigatorkvlassakov@partners.org
3 Previous Clinical Trials
202 Total Patients Enrolled
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top